Company Filing History:
Years Active: 2018
Title: Silke Möschter: Innovator in Tamper-Resistant Formulations
Introduction
Silke Möschter is a prominent inventor based in Kö'ln, Germany. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of tamper-resistant medications. Her innovative work aims to enhance patient safety and mitigate the risks associated with drug abuse.
Latest Patents
Silke holds a patent for a tamper-resistant immediate release capsule formulation comprising tapentadol. This invention is directed towards an immediate release capsule that mitigates the abuse of tapentadol or its physiologically acceptable salts by direct intravenous injection. The capsule features a tamper-resistant formulation that, when mixed with water and heated, results in a turbid, bubbling mixture that is not injectable with a standard insulin syringe. This innovative approach addresses a critical need in the pharmaceutical industry.
Career Highlights
Silke Möschter is currently employed at Grünenthal GmbH, a company known for its commitment to developing innovative pain management solutions. Her work at Grünenthal has positioned her as a key player in the pharmaceutical sector, where she continues to push the boundaries of drug formulation and safety.
Collaborations
Throughout her career, Silke has collaborated with notable colleagues, including Ingo Friedrich and Richard Fuhrherr. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Silke Möschter's contributions to the field of pharmaceutical formulations, particularly her tamper-resistant capsule invention, highlight her dedication to improving patient safety and combating drug abuse. Her work at Grünenthal GmbH and collaborations with esteemed colleagues further underscore her impact in the industry.